½É±Ù°æ»ö ¹ß»ý Ãʱ⠰íÀ§Çè ȯÀÚ¿¡¼­ Wearable Cardioverter-DefibrillatorÀÇ »ç¿ë
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

International Journal of Arrhythmia 2015³â 16±Ç 2È£ p.106 ~ p.107

¹Ú½ÂÁß(Park Seung-Jung) - Sungkyunkwan University School of Medicine Samsung Medical Center Department of Internal Medicine

Abstract

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Decreased 1.4% of cardiac sudden arrest after MI (40days, 3 Months).
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå